[Family support upon immediate cystic fibrosis announcement]

Maya Kirszenbaum1, Sophie Dupont1

  • 1CRMR Mucoviscidose, Hôpital universitaire Necker-Enfants malades, 149, rue de Sèvres, 75015 Paris, France.

Revue De L'Infirmiere
|March 10, 2020
PubMed

Insights

Cystic fibrosis (CF) impacts children's mental health and family dynamics. Psychological support is crucial for patients and families to cope with this chronic, incurable condition.

Area of Science:

  • Pediatric Psychology
  • Chronic Illness Management
  • Family Systems Theory

Background:

  • Cystic fibrosis is a rare, hereditary, and chronic disease.
  • The condition significantly affects the psychological functioning of affected children and their families.
  • The incurable nature of cystic fibrosis necessitates continuous adaptation.

Purpose of the Study:

  • To highlight the psychological impact of cystic fibrosis on children and families.
  • To emphasize the role of psychologists in supporting adaptation to cystic fibrosis.
  • To promote strategies for improving quality of life for individuals with cystic fibrosis.

Main Methods:

  • Qualitative analysis of patient and family experiences.
  • Psychological assessment of coping mechanisms.
  • Intervention strategies evaluation for chronic disease management.

Main Results:

  • Cystic fibrosis presents unique challenges to mental well-being in children.
  • Families require tailored psychological support to navigate the disease trajectory.
  • Effective coping strategies are vital for long-term adjustment.

Conclusions:

  • Psychological support is integral to comprehensive cystic fibrosis care.
  • Empowering families with coping mechanisms enhances patient outcomes.
  • Ongoing research into psychosocial interventions can improve lives affected by cystic fibrosis.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
387
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
647
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
230
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
233
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
377
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
565